Overview

Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty

Status:
Completed
Trial end date:
2017-03-30
Target enrollment:
Participant gender:
Summary
The primary objective is to study the effect of Denosumab on Bone Mineral Density, Standardised Uptake Value and bone metabolism in patients with total hip arthroplasty. The primary hypothesis is to demonstrate that Denosumab is superior to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Hans Mallmin
Treatments:
Denosumab